1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Novel cellular therapies for leukemia: CAR-modified T cells targeted to the CD19 antigen
    Journal Article

    Brentjens, R. J.; Curran, K. J.
    Hematology-American Society of Hematology Education Program (2012)

    Fulltext@MSK | Save
  • BK Polyomavirus (BKV) IgG Is A Predictor Of High Level BKV Viruria After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
    Meeting Abstract

    Lee, Y. J.; Chung, D.; Figueroa, C.; Amigues, I.; Son, T.; Hester, J.; Jakubowski, A.; Papanicolaou, G.
    Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy (2012)

    Fulltext@MSK | Save
  • How do CARs work? Early insights from recent clinical studies targeting CD19
    Journal Article

    Davila, M. L.; Brentjens, R.; Wang, X. Y.; Riviere, I.; Sadelain, M.
    OncoImmunology (2012)

    Fulltext@MSK | Save
  • Phase i clinical, pharmacokinetic, and pharmacodynamic study of KOS-862 (Epothilone D) in patients with advanced solid tumors and lymphoma
    Journal Article

    Konner, J.; Grisham, R. N.; Park, J.; O'Connor, O. A.; Cropp, G.; Johnson, R.; Hannah, A. L.; Hensley, M. L.; Sabbatini, P.; Mironov, S.; more...
    Investigational New Drugs (2012)

    Fulltext@MSK | Save
  • An enhanced international prognostic index (IPI) for patients with diffuse large B-cell lymphoma (DLBCL) in the rituximab era using the National Comprehensive Cancer Network (NCCN) database
    Meeting Abstract

    Zhou, Z.; Rademaker, A. W.; Gordon, L. I.; LaCasce, A. S.; Vanderplas, A.; Crosby-Thompson, A.; Zelenetz, A. D.; Abel, G. A.; Rodriguez, M. A.; Nademanee, A.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Reactive polyclonal gammopathy associated with polyclonal plasmacytosis is common in patients with multiple myeloma receiving prolonged lenalidomide therapy: A retrospective study of 104 patients
    Meeting Abstract

    Zamarin, D.; Devlin, S.; Arcila, M.; Giralt, S. A.; Landau, H.; Lesokhin, A.; Lendvai, N.; Chung, D.; Chimento, D.; Babu, D.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Human dendritic cell heterogeneity: Opportunities and challenges for the control of immunity
    Meeting Abstract

    Young, J. W.
    Blood (2012)

    Fulltext@MSK | Save
  • Fractionated stem cell infusions for patients with multiple myeloma undergoing autologous stem cell transplant
    Meeting Abstract

    Wood, K.; Giralt, S. A.; Koehne, G.; Chung, D.; Lendvai, N.; Hassoun, H.; Lesokhin, A.; Hoover, E.; Devlin, S.; Landau, H.
    Blood (2012)

    Fulltext@MSK | Save
  • A targeted mutational landscape of angioimmunoblastic T-cell lymphoma: Association between advanced age and mutations in TET2 and DNMT3A
    Meeting Abstract

    Weigert, O.; Kopp, N.; Bolla, S.; Odejide, O.; Toscano, D.; Lunning, M. A.; Teruya-Feldstein, J.; Louissaint, A.; Rodig, S. J.; Horwitz, S. M.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Practically all patients with acute myeloid leukemia (AML) in continuous complete remission for 3 years or more are cured of their disease: The ECOG experience
    Meeting Abstract

    Watts, J. M.; Zickl, L.; Litzow, M. R.; Luger, S. M.; Lazarus, H. M.; Cassileth, P. A.; Fernandez, H. F.; Douer, D.; Paietta, E.; Rowe, J. M.; more...
    Blood (2012)

    Fulltext@MSK | Save